drugset / Trial / NCT00504816

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

NCT00504816

Phase 1 Completed 22 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to demonstrate a lack of effect of multiple doses of GSK189075 on the PK of an oral contraceptive pill in healthy female subjects. To estimate the effects of GSK189075 on hormonal levels and on birth control.

Timeline

Start
2007-04
Primary completion
2008-01
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Brevicon Unknown
Subject remogliflozin etabonate Small molecule